cetirizine has been researched along with Cough in 6 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated substance P contents in NLF specimens were associated with ICS in patients with chronic nonproductive cough, suggesting a neurochemical abnormality in the upper airway." | 7.72 | Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. ( Cho, YS; Lee, CK; Moon, HB; Park, SY; Yoo, B, 2003) |
| "This study shows that cetirizine treatment reduces cough intensity (P < 0." | 6.68 | Cetirizine treatment of allergic cough in children with pollen allergy. ( Canonica, GW; Ciprandi, G; Fasce, L; Fregonese, L; Passalacqua, G; Ricca, V; Tosca, M, 1997) |
| "The pharmacokinetic/pharmacodynamic profile of levocetirizine was studied in 15 toddlers suffering from recurrent cough and other allergy-related symptoms, aged 20." | 5.11 | Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile. ( Cranswick, N; Fuchs, M; Hulhoven, R; Turzíkova, J, 2005) |
| "Elevated substance P contents in NLF specimens were associated with ICS in patients with chronic nonproductive cough, suggesting a neurochemical abnormality in the upper airway." | 3.72 | Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. ( Cho, YS; Lee, CK; Moon, HB; Park, SY; Yoo, B, 2003) |
| " Secondary end-points were the rate of control of chronic cough at each step of therapy, the duration of treatment required, changes in cough symptom score, health-related quality of life and possible adverse effects." | 2.75 | Efficacy and safety of modified sequential three-step empirical therapy for chronic cough. ( Li, X; Liang, S; Liu, B; Lü, H; Qiu, Z; Wang, L; Wang, Y; Wei, W; Yu, L, 2010) |
| "This study shows that cetirizine treatment reduces cough intensity (P < 0." | 2.68 | Cetirizine treatment of allergic cough in children with pollen allergy. ( Canonica, GW; Ciprandi, G; Fasce, L; Fregonese, L; Passalacqua, G; Ricca, V; Tosca, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, W | 1 |
| Yu, L | 1 |
| Wang, Y | 1 |
| Li, X | 1 |
| Qiu, Z | 2 |
| Wang, L | 1 |
| Liu, B | 1 |
| Liang, S | 1 |
| Lü, H | 1 |
| Maiello, N | 1 |
| Del Giudice, MM | 1 |
| Capristo, C | 1 |
| Decimo, F | 1 |
| Santaniello, F | 1 |
| Perrone, L | 1 |
| Boner, A | 1 |
| Cho, YS | 1 |
| Park, SY | 1 |
| Lee, CK | 1 |
| Yoo, B | 1 |
| Moon, HB | 1 |
| Cranswick, N | 1 |
| Turzíkova, J | 1 |
| Fuchs, M | 1 |
| Hulhoven, R | 1 |
| Ciprandi, G | 1 |
| Tosca, M | 1 |
| Ricca, V | 1 |
| Passalacqua, G | 1 |
| Fregonese, L | 1 |
| Fasce, L | 1 |
| Canonica, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy and Safety of Levocetirizine Dihydrochloride Oral Drops Given 0.125 mg/kg b.i.d. During 90 Days in the Treatment of Recurrent Cough Associated With Other Allergic Symptoms, e.g. Wheezing, in Children Aged 1-2 Years.[NCT00520754] | Phase 2 | 15 participants (Actual) | Interventional | 2001-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for cetirizine and Cough
| Article | Year |
|---|---|
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough.
Topics: Adult; Aminophylline; Antitussive Agents; Budesonide; Cetirizine; Chlorpheniramine; Chronic Disease; | 2010 |
Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
Topics: Age Factors; Cetirizine; Cough; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Male | 2005 |
Cetirizine treatment of allergic cough in children with pollen allergy.
Topics: Adolescent; Anti-Allergic Agents; Cetirizine; Child; Cough; Double-Blind Method; Female; Humans; Mal | 1997 |
3 other studies available for cetirizine and Cough
| Article | Year |
|---|---|
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorpha | 2009 |
Severe allergic reaction to lactulose in a child with milk allergy.
Topics: Albuterol; Anti-Allergic Agents; Cetirizine; Cheese; Child, Preschool; Cough; Humans; Immunoglobulin | 2011 |
Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin.
Topics: Administration, Inhalation; Adult; Capsaicin; Case-Control Studies; Cetirizine; Chronic Disease; Cou | 2003 |